Cargando…

Community-acquired fulminant Clostridioides (Clostridium) difficile infection by ribotype 027 isolate in Japan: a case report

BACKGROUND: Clostridioides (Clostridium) difficile infection (CDI) has become an increasingly significant disease not only as healthcare-associated infection, but also as community-acquired (CA) infection worldwide. CDI caused by the NAP1/BI/027 strain is reported to be more severe, difficult to cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiraki, Masayuki, Suzuki, Rei, Tanaka, Nobuo, Fukunaga, Hiroki, Kinoshita, Yoshinori, Kimura, Hayato, Tsutsui, Shusaku, Murata, Masaru, Morita, Shunji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187545/
https://www.ncbi.nlm.nih.gov/pubmed/34101061
http://dx.doi.org/10.1186/s40792-021-01220-9
_version_ 1783705150908530688
author Hiraki, Masayuki
Suzuki, Rei
Tanaka, Nobuo
Fukunaga, Hiroki
Kinoshita, Yoshinori
Kimura, Hayato
Tsutsui, Shusaku
Murata, Masaru
Morita, Shunji
author_facet Hiraki, Masayuki
Suzuki, Rei
Tanaka, Nobuo
Fukunaga, Hiroki
Kinoshita, Yoshinori
Kimura, Hayato
Tsutsui, Shusaku
Murata, Masaru
Morita, Shunji
author_sort Hiraki, Masayuki
collection PubMed
description BACKGROUND: Clostridioides (Clostridium) difficile infection (CDI) has become an increasingly significant disease not only as healthcare-associated infection, but also as community-acquired (CA) infection worldwide. CDI caused by the NAP1/BI/027 strain is reported to be more severe, difficult to cure, and frequently associated with recurrences in North America and Europe. CASE PRESENTATION: A 68-year-old woman was referred to our hospital for continuous lower abdominal pain 4 weeks after eradication therapy against Helicobacter pylori. While she was treated with fasting on the suspicion of ischemic colitis, she experienced septic shock. Emergent subtotal proctocolectomy revealed fulminant pseudomembranous C. difficile colitis. The C. difficile isolate recovered from the patient was identified as ribotype 027, which has been reported to be uncommon in Japan. CONCLUSION: We report a rare case of CA fulminant pseudomembranous colitis caused by ribotype 027 C. difficile after H. pylori eradication therapy.
format Online
Article
Text
id pubmed-8187545
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-81875452021-06-11 Community-acquired fulminant Clostridioides (Clostridium) difficile infection by ribotype 027 isolate in Japan: a case report Hiraki, Masayuki Suzuki, Rei Tanaka, Nobuo Fukunaga, Hiroki Kinoshita, Yoshinori Kimura, Hayato Tsutsui, Shusaku Murata, Masaru Morita, Shunji Surg Case Rep Case Report BACKGROUND: Clostridioides (Clostridium) difficile infection (CDI) has become an increasingly significant disease not only as healthcare-associated infection, but also as community-acquired (CA) infection worldwide. CDI caused by the NAP1/BI/027 strain is reported to be more severe, difficult to cure, and frequently associated with recurrences in North America and Europe. CASE PRESENTATION: A 68-year-old woman was referred to our hospital for continuous lower abdominal pain 4 weeks after eradication therapy against Helicobacter pylori. While she was treated with fasting on the suspicion of ischemic colitis, she experienced septic shock. Emergent subtotal proctocolectomy revealed fulminant pseudomembranous C. difficile colitis. The C. difficile isolate recovered from the patient was identified as ribotype 027, which has been reported to be uncommon in Japan. CONCLUSION: We report a rare case of CA fulminant pseudomembranous colitis caused by ribotype 027 C. difficile after H. pylori eradication therapy. Springer Berlin Heidelberg 2021-06-08 /pmc/articles/PMC8187545/ /pubmed/34101061 http://dx.doi.org/10.1186/s40792-021-01220-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Case Report
Hiraki, Masayuki
Suzuki, Rei
Tanaka, Nobuo
Fukunaga, Hiroki
Kinoshita, Yoshinori
Kimura, Hayato
Tsutsui, Shusaku
Murata, Masaru
Morita, Shunji
Community-acquired fulminant Clostridioides (Clostridium) difficile infection by ribotype 027 isolate in Japan: a case report
title Community-acquired fulminant Clostridioides (Clostridium) difficile infection by ribotype 027 isolate in Japan: a case report
title_full Community-acquired fulminant Clostridioides (Clostridium) difficile infection by ribotype 027 isolate in Japan: a case report
title_fullStr Community-acquired fulminant Clostridioides (Clostridium) difficile infection by ribotype 027 isolate in Japan: a case report
title_full_unstemmed Community-acquired fulminant Clostridioides (Clostridium) difficile infection by ribotype 027 isolate in Japan: a case report
title_short Community-acquired fulminant Clostridioides (Clostridium) difficile infection by ribotype 027 isolate in Japan: a case report
title_sort community-acquired fulminant clostridioides (clostridium) difficile infection by ribotype 027 isolate in japan: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187545/
https://www.ncbi.nlm.nih.gov/pubmed/34101061
http://dx.doi.org/10.1186/s40792-021-01220-9
work_keys_str_mv AT hirakimasayuki communityacquiredfulminantclostridioidesclostridiumdifficileinfectionbyribotype027isolateinjapanacasereport
AT suzukirei communityacquiredfulminantclostridioidesclostridiumdifficileinfectionbyribotype027isolateinjapanacasereport
AT tanakanobuo communityacquiredfulminantclostridioidesclostridiumdifficileinfectionbyribotype027isolateinjapanacasereport
AT fukunagahiroki communityacquiredfulminantclostridioidesclostridiumdifficileinfectionbyribotype027isolateinjapanacasereport
AT kinoshitayoshinori communityacquiredfulminantclostridioidesclostridiumdifficileinfectionbyribotype027isolateinjapanacasereport
AT kimurahayato communityacquiredfulminantclostridioidesclostridiumdifficileinfectionbyribotype027isolateinjapanacasereport
AT tsutsuishusaku communityacquiredfulminantclostridioidesclostridiumdifficileinfectionbyribotype027isolateinjapanacasereport
AT muratamasaru communityacquiredfulminantclostridioidesclostridiumdifficileinfectionbyribotype027isolateinjapanacasereport
AT moritashunji communityacquiredfulminantclostridioidesclostridiumdifficileinfectionbyribotype027isolateinjapanacasereport